Association between the XRCC3 Thr241Met polymorphism and risk of colorectal cancer: A meta analysis of 5,193 cases and 6,645 controls

Asian Pacific Journal of Cancer Prevention

Volumn 16, Issue 6, 2015, Pages 2263-2268

  Namazi, Abolfazl ^a   Abedinzadeh, Maryam ^a,b   Nourbaksh, Parisa ^c   Neamatzadeh, Hossein ^c  

^a SHAHID SADOUGHI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b Department of Biology Art and Sciences University ^*  (Iran)

^c KERMANSHAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Asians; Caucasians; Colorectal cancer; Polymorphism; XRCC3 Thr241Met

Indexed keywords

DNA BINDING PROTEIN; X-RAY REPAIR CROSS COMPLEMENTING PROTEIN 3;

CASE CONTROL STUDY; COLORECTAL TUMOR; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; HUMAN; META ANALYSIS; PROGNOSIS; RISK FACTOR;

CASE-CONTROL STUDIES; COLORECTAL NEOPLASMS; DNA-BINDING PROTEINS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; POLYMORPHISM, GENETIC; PROGNOSIS; RISK FACTORS;

EID: 84929180153     PISSN: 15137368     EISSN: None     Source Type: Journal    
DOI: 10.7314/APJCP.2015.16.6.2263     Document Type: Article

References (35)

1. Alanazi M, Pathan AA, Ajaj SA, et al (2013). DNA Repair Genes XRCC1, XRCC3, XPD, and OGG1 Polymorphisms among the Central Region Population of Saudi Arabia. Biol Res, 46, 161-7.
2. Arafa MA, Sallam S, Jriesat S, et al (2011). Colorectal cancer screening amongst first degree relatives of colon cancer cases in Jordan. Asian Pac J Cancer Prev, 12, 1007-11.
3. Bewick MA, Conlon MS, Lafrenie RM, et al (2006). Polymorphisms in XRCC1, XRCC3, and CCND1 and survival after treatment for metastatic breast cancer. J Clin Oncol, 24, 5645-51.
4. Brenneman MA, Wagener BM, Miller CA, et al (2002). XRCC3 controls the fidelity of homologous recombination: roles for XRCC3 in late stages of recombination. Mol Cell, 10, 387-95.
5. Canbay E, Cakmakoglu B, Zeybek U, Sozen S (2011). Association of APE1 and hOGG1 polymorphisms with colorectal cancer risk in a Turkish population. Curr Med Res Opin, 27, 1295-302.
6. Chen X, Wang Z, Yan Y, et al (2014). XRCC3 C18067T polymorphism contributes a decreased risk to both basal cell carcinoma and squamous cell carcinoma: evidence from a meta-analysi. PLoS One, 15, 84195.
7. Coory MD (2010). Comment on: Heterogeneity in meta-analysis should be expected and appropriately quantified. Int J Epidemiol, 39, 932-3.
8. Curtin K, Samowitz WS, Wolff RK, et al (2009). Assessing tumor mutations to gain insight into base excision repair sequence polymorphisms and smoking incolon cancer. Cancer Epidemiol Biomarkers Prev, 18, 3384-8.
9. Fasching PA, Gayther S, Pearce L, et al (2009). Role of genetic polymorphisms and ovarian cancer susceptibility. Mol Oncol, 3, 171-81.
10. Gil J, Ramsey D, Stembalska A, et al (2012). The C/A polymorphism in intron 11 of the XPC gene plays a crucial role in the modulation of an individual's susceptibility to sporadic colorectal cancer. Mol Biol Rep, 39, 527-34.
11. He XF, Wei W, Li JL, et al (2013). Association between the XRCC3 T241M polymorphism and risk of cancer: evidence from 157 case-control studies. Gene, 523, 10-9.
12. Higgins JP (2008). Commentary: Heterogeneity in meta-analysis should be expected and appropriately quantified. Int J Epidemiol, 37, 1158-60.
13. Huedo-Medina TB, Sanchez-Meca J, Marin-Martinez F, Botella J (2006). Assessing heterogeneity in meta-analysis: Q statistic or I2 index? Psychol Methods, 11, 193-206.
14. Improta G, Sgambato A, Bianchino G, et al (2008). Polymorphisms of the DNA repair genes XRCC1 and XRCC3 and risk of lung and colorectal cancer: a case-control study in a Southern Italian population. Anticancer Res, 28, 2941-6.
15. Jemal A, Bray F, Center MM, Ferlay J, et al (2011). Global cancer statistics. CA Cancer J Clin, 61, 69-90.
16. Jin MJ, Chen K, Song L, et al (2005). The association of the DNA repair gene XRCC3 Thr241Met polymorphism with susceptibility to colorectal cancer in a Chinese population. Cancer Genet Cytogenet, 163, 38-43.
17. Gao CM, Ding JH, Li SP, et al (2014). Polymorphisms in XRCC1 gene, alcohol drinking, and risk of colorectal cancer: a case-control study in Jiangsu Province of China. Asian Pac J Cancer Prev, 14, 6613-8.
18. Krupa R, Sliwinski T, Wisniewska-Jarosinska M, et al (2011). Polymorphisms in RAD51, XRCC2 and XRCC3 genes of the homologous recombination repair in colorectal cancer-a case control study. Mol Biol Rep, 38, 2849-54.
19. Krupa R, Blasiak J (2004). An association of polymorphism of DNA repairs genes XRCC1 and XRCC3 with colorectal cancer. J Exp Clin Cancer Res, 23, 285-94.
20. Mahmoudi T, Karimi K, Arkani M, et al (2014). Parathyroid hormone gene rs6256 and calcium sensing receptor gene rs1801725 variants are not associated with susceptibility to colorectal cancer in Iran. Asian Pac J Cancer Prev, 15, 6035-9.
21. Moghtit FZ, Aberkane MS, Le Morvan V, et al (2014). No association between XRCC3 Thr241Met and XPD Lys751Gln polymorphisms and the risk of colorectal cancer in West Algerian population: a case-control study. Med Oncol, 31, 942.
22. Moreno V, Gemignani F, Landi S, et al (2014). Polymorphisms in genes of nucleotide and base excision repair: risk and prognosis of colorectal cancer. Clin Cancer Res, 12, 2101-8.
23. Mucha B, Przybylowska-Sygut K, Dziki AJ, et al (2013). Association of Thr241Met polymorphism of XRCC3 gene with risk of colorectal cancer in the Polish population. Pol J Pathol, 64, 185-90.
24. Nissar S, Sameer AS, Lone TA, et al (2014). XRCC3 thr241met gene polymorphism and risk of colorectal cancer in Kashmir: a case control study. Asian Pac J Cancer Prev, 15, 9621-5.
25. Liu L, Miao L, Ji G, et al (2013). Association between XRCC1 and XRCC3 polymorphisms and colorectal cancer risk: a meta-analysis of 23 case-control studies. Mol Biol Rep, 40, 3943-52.
26. Pardini B, Naccarati A, Novotny J, et al (2008). DNA repair genetic polymorphisms and risk of colorectal cancer in the Czech Republic. Mutat Res, 638, 46-53.
27. Shizhong Han, Hong-Tao Zhang, Zhentian Wang, et al (2006). DNA repair gene XRCC3 polymorphisms and cancer risk: a meta-analysis of 48 case-control studies. Eur J Human Genetics, 14, 1136-44.
28. Skjelbred CF, Saebø M, Wallin H, et al (2006). Polymorphisms of the XRCC1, XRCC3 and XPD genes and risk of colorectal adenoma and carcinoma, in a Norwegian cohort: a case control study. BMC Cancer, 16, 6-67.
29. Sun H, Qiao Y, Zhang X, et al (2010). XRCC3 Thr241Met polymorphism with lung cancer and bladder cancer: a meta-analysis. Cancer Sci, 101, 1777-82.
30. Tebbs RS, Zhao Y, Tucker JD, et al (1995), Thompson LH. Correction of chromosomal instability and sensitivity to diverse mutagens by a cloned cDNA of the XRCC3 DNArepair gene. Proc Natl Acad Sci USA, 92, 6354-8.
31. Wang J, Zhao Y, Jiang J, et al (2010). Polymorphisms in DNA repair genes XRCC1, XRCC3 and XPD, and colorectal cancer risk: a case-control study in an Indian population. J Cancer Res Clin Oncol, 136, 1517-25.
32. Yeh CC, Sung FC, Tang R, et al (2005). Polymorphisms of the XRCC1, XRCC3, & XPD genes, and colorectal cancer risk: a case-control study in Taiwan. BMC Cancer, 5, 12.
33. Zhou CP, Pan HZ, Li FX, et al (2014). Association analysis of colorectal cancer susceptibility variants with gastric cancer in a ChineseHan population. Genet Mol Res, 13, 3673-80.
34. Zhan P, Wang Q, Qian Q, Yu LK (2013). XRCC3 Thr241Met gene polymorphisms and lung cancer risk: a meta-analysis. J Exp Clin Cancer Res, 32, 1.
35. Zhao Y, Deng X, Wang Z, et al (2012). Genetic polymorphisms of DNA repair genes XRCC1 and XRCC3 and risk of colorectal cancer in Chinese population. Asian Pac J Cancer Prev, 13, 665-9.